No Picture
News

FDA sets Dec. 17 review date after Moderna reports further success with Covid vaccine

Cambridge biotech Moderna Inc. will submit its first-ever application for drug approval today after new trial data shows its Covid-19 vaccine is 94% effective at preventing the virus. 

Moderna (Nasdaq: MRNA) identified 196 cases of Covid among the 30,… […]

No Picture
News

Bridging the gap: Building tomorrow’s STEM talent requires deep industry engagement today

The day started unremarkably enough. Sarmed Anwar, who had immigrated to the United States with his family, went to his science class at Berkeley High School as usual. But instead of covering the typical course material that day, a group of people came… […]

No Picture
News

New Publication from I-SPY 2 Trial Highlights Signatera’s Ability to Predict Treatment Outcomes in Neoadjuvant Breast Cancer Patients

Study published in Annals of Oncology validates Signatera(TM) for use in neoadjuvant treatment response monitoring

SAN CARLOS, Calif., Nov. 30, 2020 /PRNewswire/ — Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, to… […]

No Picture
News

Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #Bomedemstat–Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong […]